摘要
近年来我国高血压的发病率明显上升,已成为我国常见病之一。尤其是顽固性高血压,其病程较长,血压较高且难以控制,是危及心、脑、肾脏健康的一种血压状态,极易引起严重并发症或死亡,需要积极地治疗。治疗中应通过动态血压监测检出那些假性高血压患者,了解顽固性高血压原因和顽固性高血压临床表现,强调生活方式干预,评估患者服药的依从性以及个体的风险,了解药物的相互作用并选择合理的联合治疗方案进行血压控制。在应用最佳的治疗方案血压仍控制欠佳时,可采用新型的降压药物或经皮导管肾脏交感神经去除术来控制血压,为难治性高血压的治疗带来了新的希望。
In recent years,the incidence of hypertension in China has increased significantly,which has become a common disease in China. In particular,refractory hypertension has a long course and high blood pressure and is hard to control,which is a blood pressure condition that endangers heart,brain and kidney health,and easy to cause serious complications or death and requires active treatment. In the treatment,patients with pseudo hypertension should be detected by ambulatory blood pressure monitoring, to understand the causes and clinical manifestations of refractory hypertension,to emphasize the lifestyle intervention,to assess patient compliance and individual risk,to understand the drug interactions and choose a reasonable combination regimen for blood pressure control. When the blood pressure is still not well controlled under the best treatment,a new type of antihypertensive drug or percutaneous renal sympathetic nerve removal can be used to control blood pressure,which brings new hope for the treatment of refractory hypertension.
作者
田志峰
TIAN Zhi-feng(Department of Internal Medicine,Liulin Hospital of Tianjin Hexi District,Tianjin 300350,Chin)
出处
《中国城乡企业卫生》
2018年第7期26-28,共3页
Chinese Journal of Urban and Rural Enterprise Hygiene
关键词
顽固性高血压
病因
治疗
药物研发
Resistant hypertension
Pathogeny
Treatment
Drug development
